ダウンロード数: 392

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
TP.0000000000000025.pdf1.95 MBAdobe PDF見る/開く
タイトル: Graft reconditioning with nitric oxide gas in rat liver transplantation from cardiac death donors.
著者: Kageyama, Shoichi
Yagi, Shintaro  KAKEN_id  orcid https://orcid.org/0000-0001-7465-5761 (unconfirmed)
Tanaka, Hirokazu
Saito, Shunichi
Nagai, Kazuyuki
Hata, Koichiro  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-3609-6396 (unconfirmed)
Fujimoto, Yasuhiro
Ogura, Yasuhiro
Tolba, Rene
Shinji, Uemoto  KAKEN_id
著者名の別形: 影山, 詔一
八木, 真太郎
キーワード: Cardiac death donor
Organ preservation
Ischemia-reperfusion injury
Warm ischemia
Liver transplantation
発行日: 27-Mar-2014
出版者: Lippincott Williams & Wilkins
誌名: Transplantation
巻: 97
号: 6
開始ページ: 618
終了ページ: 625
抄録: Background: Liver transplant outcomes using grafts donated after cardiac death (DCD) remain poor. Methods: We investigated the effects of ex vivo reconditioning of DCD grafts with venous systemic oxygen persufflation using nitric oxide gas (VSOP-NO) in rat liver transplants. Orthotopic liver transplants were performed in Lewis rats, using DCD grafts prepared using static cold storage alone (group-control) or reconditioning using VSOP-NO during cold storage (group-VSOP-NO). Experiment I: In a 30-min warm ischemia model, graft damage and hepatic expression of inflammatory cytokines, endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS), and endothelin-1 (ET-1) were examined, and histologic analysis was performed 2, 6, 24, and 72 hr after transplantation. Experiment II: In a 60-min warm ischemia model, grafts were evaluated 2 hr after transplantation (6 rats/group), and survival was assessed (7 rats/group). Results: Experiment I: Group-VSOP-NO had lower alanine aminotransferase (ALT) (P<0.001), hyaluronic acid (P<0.05), and malondialdehyde (MDA) (P<0.001), hepatic interleukin-6 expression (IL-6) (P<0.05), and hepatic tumor necrosis factor-alpha (TNF-[alpha]) expression (P<0.001). Hepatic eNOS expression (P<0.001) was upregulated, whereas hepatic iNOS (P<0.01) and ET-1 (P<0.001) expressions were downregulated. The damage of hepatocyte and sinusoidal endothelial cells (SECs) were lower in group-VSOP-NO. Experiment II: VSOP-NO decreased ET-1 and 8-hydroxy-2'deoxyguanosine (8-OHdG) expression and improved survival after transplantation by 71.4% (P<0.01). Conclusion: These results suggest that VSOP-NO effectively reconditions warm ischemia-damaged grafts, presumably by decreasing ET-1 upregulation and oxidative damage.
著作権等: © 2014 by Lippincott Williams & Wilkins
この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。
This is not the published version. Please cite only the published version.
URI: http://hdl.handle.net/2433/198289
DOI(出版社版): 10.1097/TP.0000000000000025
PubMed ID: 24521773
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。